Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,556 | 59,473 | 92,828 | 76,965 | 153,677 |
| Marketable Securities | 346,757 | 347,382 | 334,980 | 351,801 | 268,803 |
| Receivables | 27,516 | 46,144 | 28,337 | 46,164 | 45,250 |
| Other current assets | 29,879 | 0 | 29,095 | 0 | 0 |
| TOTAL | $487,015 | $477,353 | $508,018 | $496,335 | $493,105 |
| Non-Current Assets | |||||
| PPE Net | 1,002 | 3,059 | 3,281 | 3,799 | 4,610 |
| Other Non-Current Assets | 10,580 | 22,945 | 15,724 | 22,940 | 25,509 |
| TOTAL | $11,582 | $26,004 | $19,005 | $26,739 | $30,119 |
| Total Assets | $498,597 | $503,357 | $527,023 | $523,074 | $523,224 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 86,364 | 147,060 | 103,780 | 139,959 | 137,244 |
| TOTAL | $151,427 | $151,036 | $168,161 | $143,853 | $145,281 |
| Non-Current Liabilities | |||||
| Long Term Debt | 713,859 | 716,885 | 539,782 | 530,408 | 575,815 |
| Other Non-Current Liabilities | 3,144 | 7,197 | 3,042 | 4,843 | 5,323 |
| TOTAL | $717,003 | $724,082 | $542,824 | $535,251 | $581,138 |
| Total Liabilities | $868,430 | $875,118 | $710,985 | $679,104 | $726,419 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,798 | 29,709 | 29,693 | 29,547 | 33,201 |
| Common Shares | 30 | 30 | 30 | 30 | 33 |
| Retained earnings | -2,383,516 | -2,375,988 | -2,489,772 | -2,453,492 | -2,449,860 |
| Other shareholders' equity | -2,548 | -3,487 | -2,873 | -2,964 | -2,865 |
| TOTAL | $-369,833 | $-371,761 | $-183,962 | $-156,030 | $-203,195 |
| Total Liabilities And Equity | $498,597 | $503,357 | $527,023 | $523,074 | $523,224 |